The clinical success of platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin is still limited by severe side effects and the frequent emergence of resistance, highlighting the need for new metal-based anticancer agents. Among potential alternat... ...

请注册登录后继续浏览